Retatrutide (50mg)
$240.00$210.00
A high-purity synthetic 39-amino-acid triple Glucose-Dependent Insulinotropic Polypeptide (GIP), Glucagon-Like Peptide-1 (GLP-1), and Glucagon receptor triagonist engineered to $\ge$99% purity. Supplied in a high-capacity 50mg vial as a stabilized lyophilized powder for large-scale metabolic pathway research, multi-receptor signaling kinetics, and in vitro cellular assays.
Product Overview
Retatrutide (50mg) is a high-yield formulation of the novel single-peptide triple receptor agonist designed to simultaneously bind and activate three distinct metabolic pathways: the GIP receptor, the GLP-1 receptor, and the glucagon receptor. By integrating these three synergistic pathways into one engineered structure, Retatrutide combines glucose-dependent insulin secretion, central satiety signaling, delayed gastric emptying, and glucagon-mediated hepatic lipid oxidation and energy expenditure.
In high-throughput metabolic, endocrinological, and obesity research models, triple-agonism represents the leading edge of incretin and metabolic signaling studies. This 50mg format offers research facilities an extended supply standard for high-volume comparative, analytical, and cellular assays.
Key Research Applications
Triple-Receptor Signaling Kinetics: Engineered to analyze simultaneous activation dynamics across GIP, GLP-1, and glucagon receptors, downstream intracellular cAMP synthesis, and cross-pathway signaling cascade interaction.
Hepatic Lipid Oxidation & Energy Expenditure: Ideal for studying glucagon-driven lipid metabolism, hepatic beta-oxidation, mitochondrial respiration increases, and energy balance dynamics in vitro.
Glycemic Control & Metabolic Synergy: Utilized to observe glucose-dependent insulinotropic stimulation, glucagon modulation, and pancreatic islet cell responses.
Analytical Characterization: Serves as a high-grade reference standard for High-Performance Liquid Chromatography (HPLC) and quantitative mass spectrometry workflows.
Technical Specifications
Compound Name: Retatrutide
CAS Number: 2381089-83-2
Molecular Formula: $\text{C}_{221}\text{H}_{342}\text{N}_{48}\text{O}_{68}$
Molecular Weight: 4731.33 g/mol
Purity Grade: $\ge$99% (COA-Verified)
Physical Form: Lyophilized Powder
Net Quantity: 50 mg per vial
Category Focus: Metabolic Pathway Research
Quality Assurance & Laboratory Protocols
Every batch of Retatrutide undergoes rigorous third-party analytical validation—including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)—to confirm exact amino acid sequence fidelity, fatty acid chain integration, and purity standards. Batch-specific Certificates of Analysis (COA) and Safety Data Sheets (SDS) are provided to support complete institutional compliance.
Storage Instructions: Store unopened lyophilized vials in a dry, dark environment at $-20^\circ\text{C}$. Following initial reconstitution for laboratory workflows, maintain under refrigeration at $2^\circ\text{C}$ to $8^\circ\text{C}$. Refer to the Safety Data Sheet (SDS) for complete chemical handling guidance.
Research Disclaimer: This product is strictly supplied for in vitro, analytical, and laboratory research purposes only. It is not intended for human or veterinary use, consumption, administration, injection, diagnostic procedures, or therapeutic applications.